Basic Information
ID: ALA5136655
Type: Binding
Description: Inhibition of recombinant SARS CoV-1 main protease expressed using MCA-AVLQSGFR-K(DNP)-K-NH2 as substrate incubated for 2 hrs by FRET based assay
Organism: Severe acute respiratory syndrome-related coronavirus
Activity Charts
Bioactivity
Activity Types for Assay ALA5136655
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 403.48 | 1.54 | 1.54 |
| 255.30 | 2.89 | 2.89 |
| 275.36 | 3.26 | 3.26 |
| 282.32 | 3.67 | 3.67 |
| 267.31 | 2.96 | 2.96 |
| 275.36 | 3.26 | 3.26 |
| 275.36 | 3.26 | 3.26 |
| 286.38 | 3.93 | 3.93 |
| 310.40 | 4.71 | 4.71 |
| 275.36 | 3.26 | 3.26 |
| 289.39 | 3.27 | 3.27 |
| 291.36 | 2.96 | 2.96 |
| 261.33 | 2.95 | 2.95 |
| 307.43 | 3.67 | 3.67 |
| 269.33 | 3.20 | 3.20 |
| 326.40 | 3.77 | 3.77 |
| 377.29 | 4.90 | 4.90 |